$3.05 (1.67%)

Volume: 198.092k

Closed: Mar 21, 2023

Hollow Logo Score: 1.337
ESSA Pharma Inc. Stock
$3.05 (1.67%)

Volume: 198.092k

Closed: Mar 21, 2023

Score Hollow Logo 1.337

ESSA Pharma Inc. Stock Company Profile

999 West Broadway, Suite 720

Vancouver BC V5Z 1K5



Industry: Biotechnology

Sector: Healthcare

ESSA Pharma Inc.


ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE